The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
A chemokine receptor CCR-1 antagonist reduces renal fibrosis after unilateral ureter ligation
Open accessAbstract
The expression of chemokines and their receptors is thought to contribute to leukocyte infiltration and progressive renal fibrosis after unilateral ureter obstruction (UUO). We hypothesized that blocking the chemokine receptor CCR1 using the nonpeptide antagonist BX471 could reduce leukocyte infiltration and renal fibrosis after UUO. UUO kidneys from BX471-treated mice (day 0-10 and day 6-10) revealed a 40-60% reduction of interstitial macrophage and lymphocyte infiltrate compared with controls. Treated mice also showed a marked reduction of CCR1 and CCR5 mRNA levels, and FACS analysis showed a comparable reduction of CD8+/CCR5+ T cells. Markers of renal fibrosis, such as interstitial fibroblasts, interstitial volume, mRNA and protein expression for collagen I, were all significantly reduced by BX471-treatment compared with vehicle controls. By contrast treatment was ineffective when the drug was supplied only from days 0 to 5. In summary, blockade of CCR1 substantially reduces cell accumulation and renal fibrosis after UUO. Most interestingly, late onset of treatment is also effective. We therefore conclude that CCR1 blockade may represent a new therapeutic strategy for reducing cellular infiltration and renal fibrosis as major factors in the progression to end-stage renal failure.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Qin, S., Rottman, J. B., Myers, P., Kassam, N., Weinblatt, M., Loetscher, M., Koch, A. E., Moser, B., & Mackay, C. R. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1422 · Cited by 1,359
Research works printed but not linked: 26
- 10.1097/00041552-200003000-00006 · DOI
- 10.1097/00041552-200105000-00004 · DOI · Paper page
- 10.1016/S1074-7613(00)80165-X · DOI · Paper page
- Segerer, 2000, J Am Soc Nephrol, 11, 152, 10.1681/ASN.V111152 · DOI · Paper page
- Segerer, 2001, Am J Kidney Dis, 37, 518, 10.1053/ajkd.2001.22076 · doi:10.1053/ajkd.2001.22076 · Paper page
- 10.1159/000013603 · DOI
- Diamond, 1998, Semin Nephrol, 18, 594
- Vielhauer, 2001, J Am Soc Nephrol, 12, 1173, 10.1681/ASN.V1261173 · DOI · Paper page
- 10.1074/jbc.M001222200 · DOI · Paper page
- 10.1074/jbc.M007457200 · DOI
- 10.1016/S0165-2478(01)00172-9 · DOI
- 10.1038/363274a0 · DOI · Paper page
- 10.1006/abio.1999.4061 · DOI · Paper page
- 10.1074/jbc.273.25.15687 · DOI
- 10.1016/S0014-2999(99)00863-8 · DOI
- 10.1083/jcb.130.2.393 · DOI · Paper page
- Mack, 2001, J Immunol, 166, 4697, 10.4049/jimmunol.166.7.4697 · DOI · Paper page
- Anders, 2001, J Am Soc Nephrol, 12, 919, 10.1681/ASN.V125919 · DOI
- Murphy, 2000, Pharmacol Rev, 52, 145
- 10.1182/blood.V97.4.1144 · DOI · Paper page
- Tokuda, 2000, J Immunol, 164, 2745, 10.4049/jimmunol.164.5.2745 · DOI
- 10.1002/(SICI)1521-4141(199906)29:06<2037::AID-IMMU2037>3.0.CO;2-V · DOI · Paper page
- Kaufmann, 2001, J Leukoc Biol, 69, 248, 10.1189/jlb.69.2.248 · DOI
- Segerer, 1999, Kidney Int, 56, 52, 10.1046/j.1523-1755.1999.00544.x · DOI · Paper page
- 10.1016/S0140-6736(00)04898-4 · DOI · Paper page
- Zeisberg, 2000, J Nephrol, 3, S111
Cited by
Cellular and molecular mechanisms of fibrosis
Wynn, T. (2008) · The Journal of Pathology · doi:10.1002/path.2277 · Cited by 4,495
Fibrotic disease and the TH1/TH2 paradigm
Wynn, T. A. (2004) · Nature Reviews Immunology · doi:10.1038/nri1412 · Cited by 1,765
Cellular and molecular mechanisms of renal fibrosis
Liu, Y. (2011) · Nature Reviews Nephrology · doi:10.1038/nrneph.2011.149 · Cited by 1,446
Molecular mechanisms of diabetic kidney disease
Reidy, K., Kang, H. M., Hostetter, T., & Susztak, K. (2014) · Journal of Clinical Investigation · doi:10.1172/jci72271 · Cited by 909
Galectin-3 Expression and Secretion Links Macrophages to the Promotion of Renal Fibrosis
Henderson, N. C., Mackinnon, A. C., Farnworth, S. L., Kipari, T., Haslett, C., Iredale, J. P., Liu, F.-T., Hughes, J., & Sethi, T. (2008) · The American Journal of Pathology · doi:10.2353/ajpath.2008.070726 · Cited by 562
Metadata
- Authors
- Anders, H.-J., Vielhauer, V., Frink, M., Linde, Y., Cohen, C. D., Blattner, S. M., Kretzler, M., Strutz, F., Mack, M., Gröne, H.-J., Onuffer, J., Horuk, R., Nelson, P. J., & Schlöndorff, D.
- Venue
- Journal of Clinical Investigation
- Published
- 2002-01-15
- Volume
- 109
- Issue
- 2
- Pages
- 251-259
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2100288510
- Cited by
- 207
- References
- 1
- FWCI
- 10.42
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A chemokine receptor CCR-1 antagonist reduces renal fibrosis after unilateral ureter ligation. https://app.cochat.ai/papers/10.1172/jci14040
- The paper
- Anders, H.-J., Vielhauer, V., Frink, M., Linde, Y., Cohen, C. D., Blattner, S. M., Kretzler, M., Strutz, F., Mack, M., Gröne, H.-J., Onuffer, J., Horuk, R., Nelson, P. J., & Schlöndorff, D. (2002). A chemokine receptor CCR-1 antagonist reduces renal fibrosis after unilateral ureter ligation. Journal of Clinical Investigation. https://doi.org/10.1172/jci14040
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
